A Phase 2 study to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and efficacy of sutacimig for prophylaxis in glanzmann thrombasthenia: A trial in progress
Year: 2025
Type: conference-abstract
Source: Blood
Authors: Paul Saultier, Suthesh Sivapalaratnam, Frederico Xavier, Laurent Frenzel, Andrea Artoni, Roger Schutgens, Roseline d'Oiron, Keith Gomez, Gillian Lowe, Julie Tarrant, Rajiv Pruthi, Jenny Zhou, Maissaa Janbain, Ulrike Lorch, Ashley Gosnell, Ally He, Michael Kelly, Quentin Van Thillo, Peter Verhamme
Institutions: Hôpital de la Timone, Queen Mary University of London, Barts Health NHS Trust, University of Pittsburgh, Hôpital Necker-Enfants Malades, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, University Medical Center Utrecht, Bicêtre Hospital, Royal Free London NHS Foundation Trust, The Royal Free Hospital, University Hospitals Birmingham NHS Foundation Trust, St James's University Hospital, University of California San Diego, Tulane University, Richmond Pharmacology Limited (United Kingdom), Cambridge Public School, KU Leuven
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4417015338
Cites:
Cited by:
Related to: